King Luther Capital Management Corp Has $9.24 Million Holdings in Synopsys, Inc. $SNPS

by · The Cerbat Gem

King Luther Capital Management Corp lessened its stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 33.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 19,676 shares of the semiconductor company’s stock after selling 9,783 shares during the quarter. King Luther Capital Management Corp’s holdings in Synopsys were worth $9,242,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Synopsys during the 4th quarter worth about $28,000. Oakworth Capital Inc. raised its holdings in Synopsys by 3,700.0% during the 4th quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock worth $36,000 after buying an additional 74 shares during the period. KERR FINANCIAL PLANNING Corp acquired a new stake in Synopsys during the 3rd quarter worth about $38,000. WealthCollab LLC raised its holdings in Synopsys by 110.8% during the 3rd quarter. WealthCollab LLC now owns 78 shares of the semiconductor company’s stock worth $38,000 after buying an additional 41 shares during the period. Finally, N.E.W. Advisory Services LLC raised its holdings in Synopsys by 128.6% during the 4th quarter. N.E.W. Advisory Services LLC now owns 80 shares of the semiconductor company’s stock worth $38,000 after buying an additional 45 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on SNPS. The Goldman Sachs Group set a $600.00 price objective on Synopsys and gave the stock a “buy” rating in a report on Wednesday, February 25th. Berenberg Bank set a $633.00 price objective on Synopsys in a report on Wednesday. HSBC downgraded Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective on the stock. in a report on Friday, February 20th. Rosenblatt Securities boosted their price objective on Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, Morgan Stanley restated an “equal weight” rating and set a $480.00 price objective (down from $550.00) on shares of Synopsys in a report on Wednesday, February 25th. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Synopsys presently has a consensus rating of “Hold” and an average price target of $544.88.

Check Out Our Latest Analysis on SNPS

Synopsys Price Performance

Shares of SNPS opened at $525.92 on Thursday. The company has a market capitalization of $100.75 billion, a price-to-earnings ratio of 81.66, a P/E/G ratio of 4.38 and a beta of 1.25. Synopsys, Inc. has a fifty-two week low of $376.18 and a fifty-two week high of $651.73. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26. The business’s 50-day moving average is $457.56 and its 200-day moving average is $453.69.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The firm’s quarterly revenue was up 41.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts expect that Synopsys, Inc. will post 10.28 EPS for the current fiscal year.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Synopsys beat Q2 expectations, reporting non-GAAP EPS of $3.35 versus estimates around $3.17 and revenue of $2.276 billion versus consensus near $2.25 billion, showing continued demand for its chip design software. Reuters article
  • Positive Sentiment: The company raised FY2026 guidance, now projecting EPS of $14.72 to $14.80 and revenue of roughly $9.6 billion to $9.7 billion, signaling confidence in AI-driven demand and operating momentum. Press release
  • Positive Sentiment: Synopsys reached a cooperation agreement with Elliott Investment Management and added Elliott partner Jesse Cohn to its board, which could support efforts to improve margins, governance, and shareholder value. Reuters article
  • Neutral Sentiment: Despite the strong report, the stock is reacting cautiously, suggesting some investors may be taking profits after a large run-up and waiting for proof that growth can hold up after the Ansys-related integration and portfolio changes.
  • Negative Sentiment: The market may be weighing that Q2 EPS of $3.35 was still below the prior-year $3.67, which can temper enthusiasm even with a beat versus estimates. Zacks article

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).